There is a moment in the repeated IVF failure journey that most couples recognise but few can articulate precisely. It is the point at which the clinical explanation provided after each failed cycle begins to feel insufficient where "bad luck" or "embryo quality issues" no longer seem like a complete answer when the same thing has happened three times in a row. That moment is almost always the right time to seek a second opinion, but most couples delay it by months or years, hoping the next cycle at the same clinic will produce a different result.
This guide explains what repeated IVF failure actually means clinically, what a second opinion should accomplish that a review at the original clinic cannot, what investigations are routinely missed and should be specifically requested, and how India's leading fertility centres approach this challenging patient group.
Defining the Problem: Repeated IVF Failure vs Recurrent Implantation Failure
Before deciding when to seek a second opinion, it helps to understand the distinction between two terms that are often used interchangeably but are clinically different.
The Clinical Distinction
Repeated IVF failure refers broadly to the failure to achieve a pregnancy after several IVF attempts. It encompasses all the reasons a cycle might not succeed: poor ovarian response, failed fertilisation, embryos that stop developing before transfer, or failed implantation after a transfer has occurred.
Recurrent implantation failure (RIF) is a more specific category: the inability to achieve a clinical pregnancy despite the transfer of multiple good-quality embryos across several cycles. The ESHRE good practice recommendations use the criterion of three or more failed transfers of good-quality embryos, though some authorities use two transfers of blastocysts. The distinction matters because RIF implies the embryos reached transfer quality but still did not implant, which points the investigation toward the endometrial and immune environment rather than embryo production alone.
Both categories warrant a second opinion after two to three failed cycles, but RIF in particular requires a specialist who understands the nuanced and evolving evidence base for investigating the embryo-endometrium interaction.
When the Definition Does Not Matter
Regardless of whether the clinical picture meets the formal definition of RIF, a second opinion is warranted when:
-
Two or more IVF cycles have failed with no clear explanation provided
-
Good-quality embryos including blastocysts have been transferred without success
-
No new investigation has been performed between cycles
-
The same protocol has been repeated without modification after failure
-
Early pregnancy was achieved but ended in recurrent miscarriage alongside IVF failure
The couple has been at the same clinic for more than twelve months without a successful ongoing pregnancy
Why Repeated IVF Failure Happens: The Evidence-Based Framework
Understanding why repeated IVF failure occurs is the prerequisite for a meaningful second opinion. The framework has three main pillars, and adequate investigation addresses all three.
Embryo Factors
Chromosomal abnormality in the embryo remains the most common cause of implantation failure overall. Embryos that look visually normal under standard grading can carry chromosomal errors invisible to standard assessment. The proportion of chromosomally abnormal embryos increases with maternal age but is not exclusively an age-related problem.
Karyotype abnormalities in couples experiencing RIF occur at higher rates than in the general population. In a case-control study of 100 couples with RIF, chromosomal structural abnormalities were found in a meaningful proportion of affected couples, with inversions and translocations implicated in a subset of unexplained cases. What a second opinion should check: whether PGT-A has been offered and performed, whether sperm karyotyping and chromosomal analysis of both partners has been conducted, and whether ICSI with advanced sperm selection (PICSI, MACS) was used to reduce DNA fragmentation contribution to embryo quality.
Endometrial and Uterine Factors
The endometrium is an active participant in implantation, not a passive recipient. A failure of the embryo-endometrium dialogue, rather than embryo chromosomal abnormality, is implicated in a meaningful proportion of RIF cases particularly those where PGT-A-tested euploid embryos have failed to implant. The most important endometrial factors to investigate are:
-
Chronic endometritis: A subclinical infection of the endometrial lining caused by bacteria that do not produce obvious symptoms but disrupt the implantation environment. Diagnosed by hysteroscopy with endometrial biopsy and specific CD138 immunohistochemistry staining. Antibiotic treatment normalises the endometrium and has been associated with improved implantation rates in studies of RIF patients.
-
Displaced window of implantation: The ERA test (Endometrial Receptivity Analysis) identifies whether the patient's endometrial receptivity window is shifted from the standard progesterone exposure timing assumed in frozen embryo transfer protocols. Approximately 25 percent of RIF patients have a non-receptive endometrium at the time of standard transfer.
-
Structural abnormalities: Submucosal fibroids, endometrial polyps, uterine septum, and intrauterine adhesions (Asherman's syndrome) mechanically impair implantation and are correctable. Hysteroscopy should be performed before further IVF cycles in any patient who has not had one.
-
Thin endometrium: An endometrial thickness below seven millimetres on the day of transfer is associated with reduced implantation rates. Causes include poor vascularity, prior surgery, and inadequate oestrogen preparation.
Immunological and Thrombophilic Factors
Immune-mediated implantation failure is the most contested area in RIF management, but several specific conditions have established clinical relevance:
-
Antiphospholipid syndrome (APS): Produces a prothrombotic state that impairs the initial vascularisation required for implantation. Screening for antiphospholipid antibodies (anticardiolipin, anti-beta2-glycoprotein I, lupus anticoagulant) is standard before a third IVF cycle in unexplained RIF.
-
Hereditary thrombophilia: Factor V Leiden, prothrombin gene mutations, and protein C/S deficiencies have been implicated in recurrent IVF failure through impairment of early placental vascular development. Low molecular weight heparin (LMWH) is used in thrombophilic patients during IVF cycles.
-
Natural killer cell abnormalities: Elevated uterine natural killer cells and altered peripheral NK cell ratios are found in some RIF patients. However, routine NK cell testing and treatment remains controversial and should not be offered outside a specialist RIF programme with an evidence-based protocol.
What a Genuine Second Opinion Should Cover
A second opinion after repeated IVF failure is not a review appointment at another clinic that confirms the same protocol is appropriate. It is a structured reassessment of every variable in the treatment pathway.
What to Bring to a Second Opinion
-
Complete records of every IVF cycle: stimulation protocol, doses, number of eggs retrieved, fertilisation rate, embryo development day-by-day, grading at transfer, ERA or PGT-A results if performed
-
All investigation results: hormone profile, semen analysis, sperm DNA fragmentation, hysteroscopy report, any thrombophilia or immunological testing
-
Surgical history including prior uterine procedures, ERPC, or any abdominal surgery
-
Full medication history across all cycles
What the Second Opinion Specialist Should Do
-
Review every cycle record, not just the most recent one, looking for patterns across cycles
-
Confirm whether all three pillars (embryo, endometrial, immunological) have been investigated
-
Identify which specific investigations are missing and which should be prioritised
-
Provide a written differential diagnosis of the most likely cause or causes of the failure
-
Propose a modified protocol with specific rationale for each change, not simply a different stimulation dose
What a Second Opinion Should Not Be
A second opinion should not be an appointment that ends with the same recommendation as the previous clinic without additional investigation. If the specialist at a second opinion clinic proposes to proceed with another IVF cycle without any additional workup, the investigation is incomplete. Couples with recurrent IVF failures need guidance on the appropriateness of proceeding with further IVF attempts, and if implantation fails to occur despite repeated treatment attempts or if the prognosis is considered poor, alternative treatment options ought to be explored.
Why India's Fertility Specialists Are a Strong Second Opinion Choice
For couples who have experienced repeated IVF failure in Western countries, the Gulf, or elsewhere, seeking a second opinion from India's leading fertility specialists offers specific and measurable advantages.
Concurrent Male and Female Investigation From Day One
India's top fertility centres conduct sperm DNA fragmentation testing, full thrombophilia screen, antiphospholipid antibody panel, and ERA assessment alongside the standard female evaluation from the first appointment. In many Western IVF programmes, these investigations are added only after a third or fourth failure. The concurrent approach collapses the diagnostic timeline from years to weeks.
Access to the Full Investigative Battery
ERA testing, hysteroscopy with CD138 chronic endometritis staining, PGT-A with comprehensive chromosomal screening, PICSI and MACS sperm selection, advanced NK cell assessment where clinically indicated, and thrombophilia investigation are all available at NABH-accredited fertility centres in India. The same investigations that cost USD 5,000 to USD 15,000 in the USA or UK as a bundled workup cost Rs. 50,000 to Rs. 1,50,000 (USD 600 to USD 1,800) in India.
Specialists in RIF as a Subspecialty
India's leading fertility hospitals employ reproductive endocrinologists who specifically manage RIF as a clinical subspecialty rather than as a variant of standard IVF. This means the second opinion comes from a specialist whose daily practice is built around the specific clinical challenge the couple is facing.
For couples where male-factor issues are part of the picture, read: Male Infertility Treatment for Couples Facing Recurrent IVF Failure
How Karetrip Connects Couples with Repeated IVF Failure to the Right Specialist in India
A second opinion for repeated IVF failure is only as useful as the specialist providing it. Karetrip reviews each couple's existing cycle records and investigation history before recommending a fertility centre and specialist in India, ensuring the proposed team has specific experience in RIF investigation β not just general IVF practice. Couples are matched with specialists whose clinical focus includes ERA, chronic endometritis management, thrombophilia investigation, and advanced embryo selection, based on the specific gaps identified in their previous workup.
From pre-travel record review and medical visa coordination, through accommodation near the fertility centre and discharge documentation for treatment continuation, Karetrip manages every element of the international patient journey for repeated IVF failure investigation and treatment in India.
Chat with our Medical care assistant, RUA, for quick guidance and support and take the first step toward a genuinely investigative second opinion for your repeated IVF failure.